Lilly to offer single-use vials of weight loss drug on Ro’s telemedicine platform

Telemedicine company Ro said Wednesday it will offer single-use vials of Eli Lilly’s weight-loss drug Zepbound for obese patients has become the first alternative platform for a cheaper version of the drug compared to Lilly’s own website.

Teile diesen Beitrag: